These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3036059)

  • 1. Molecular biology and immunology of cytomegalovirus.
    Griffiths PD; Grundy JE
    Biochem J; 1987 Jan; 241(2):313-24. PubMed ID: 3036059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal endothelial cells activate innate and acquired arm of anti-viral responses after cytomegalovirus infection.
    Miyazaki D; Uotani R; Inoue M; Haruki T; Shimizu Y; Yakura K; Yamagami S; Suzutani T; Hosogai M; Isomura H; Inoue Y
    Exp Eye Res; 2017 Aug; 161():143-152. PubMed ID: 28648760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune reaction to human cytomegalovirus].
    Ito M
    Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus escape from immune detection.
    Michelson S
    Intervirology; 1999; 42(5-6):301-7. PubMed ID: 10702710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
    Meyer T; Reischl U; Wolf H; Schüller C; Arndt R
    Mol Cell Probes; 1994 Aug; 8(4):261-71. PubMed ID: 7870068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Late Protein pUL31 Alters Pre-rRNA Expression and Nuclear Organization during Infection.
    Westdorp KN; Sand A; Moorman NJ; Terhune SS
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.
    Smith C; Brennan RM; Tey SK; Smyth MJ; Burrows SR; Miles JJ; Hill GR; Khanna R
    J Virol; 2016 Aug; 90(16):7497-507. PubMed ID: 27279616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection in patients with solid-organ transplant. Recently reviewed immunologic response and pathogenicity mechanisms.
    Caltenco-Serrano R; Sánchez-Huerta JL; Vargas-Jiménez R; Rodríguez-Suárez RS; Gómez-Barreto D
    Rev Latinoam Microbiol; 2001; 43(4):177-82. PubMed ID: 17061506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of CMV-encoded MHC class I homologues.
    Farrell HE; Davis-Poynter NJ; Andrews DM; Degli-Esposti MA
    Curr Top Microbiol Immunol; 2002; 269():131-51. PubMed ID: 12224506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system.
    Mocarski ES
    Cell Microbiol; 2004 Aug; 6(8):707-17. PubMed ID: 15236638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.
    Chen SF; Holmes TH; Slifer T; Ramachandran V; Mackey S; Hebson C; Arvin AM; Lewis DB; Dekker CL
    J Pediatric Infect Dis Soc; 2016 Mar; 5(1):14-20. PubMed ID: 26908487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
    Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
    J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus replication and the host immune response.
    Lang DJ; Cheung KS; Schwartz JN; Daniels CA; Harwood SE
    Yale J Biol Med; 1976 Mar; 49(1):45-58. PubMed ID: 183380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.
    Coronel R; Takayama S; Juwono T; Hertel L
    J Virol; 2015 May; 89(10):5615-32. PubMed ID: 25762731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.